Octagon Capital Advisors LP - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 117 filers reported holding DYNE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.7%.

Quarter-by-quarter ownership
Octagon Capital Advisors LP ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,208,787
-20.4%
692,9450.0%0.95%
-12.1%
Q2 2023$7,795,631
-2.3%
692,9450.0%1.08%
-5.6%
Q1 2023$7,982,726
+57.6%
692,945
+31.9%
1.15%
+4.9%
Q1 2022$5,064,000
-27.0%
525,284
-10.0%
1.10%
-18.9%
Q4 2021$6,940,000
-26.8%
583,6490.0%1.35%
-42.1%
Q3 2021$9,478,000
-22.8%
583,6490.0%2.33%
-8.2%
Q2 2021$12,280,000
+35.5%
583,6490.0%2.54%
-25.5%
Q1 2021$9,064,000
-10.4%
583,649
+21.2%
3.41%
-2.6%
Q4 2020$10,112,000481,5383.50%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders